Joseph P Dewulf1,2,3, Elsa Wiame1,2, Imen Dorboz4, Monique Elmaleh-Bergès5, Apolline Imbard6,7, Dana Dumitriu8, Malgorzata Rak4, Agnès Bourillon6,7, Raphaël Helaers9, Alisha Malla10, Florence Renaldo4,11,12, Odile Boespflug-Tanguy4,11,12, Marie-Françoise Vincent3, Jean-François Benoist6,7, Ron A Wevers13, Avner Schlessinger10, Emile Van Schaftingen1,2, Marie-Cécile Nassogne14, Manuel Schiff4,11,15. 1. Laboratory of Physiological Chemistry, de Duve Institute, Université catholique de Louvain, Brussels, Belgium. 2. Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Brussels, Belgium. 3. Department of Laboratory Medicine, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. 4. UMR1141, PROTECT, INSERM, Paris Diderot University, Sorbonne Paris Cité, Paris, France. 5. Department of Pediatric Imaging, Robert Debré University Hospital, Public APHP, Paris, France. 6. Laboratory of Biochemistry, Robert Debré University Hospital, APHP, France. 7. Paris-Sud University, Châtenay-Malabry, France. 8. Department of Pediatric Imaging, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. 9. Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium. 10. Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY. 11. Department of Pediatric Neurology and Metabolic Diseases, Robert Debré University Hospital, APHP, Paris, France. 12. Reference Center for Leukodystrophies and Rare Leukoencephalopathies, LEUKOFRANCE, Robert Debré University Hospital, APHP, Paris, France. 13. Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. 14. Pediatric Neurology Unit, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. 15. Reference Center for Inborn Errors of Metabolism, Robert Debré University Hospital, APHP, Paris, France.
Abstract
OBJECTIVE: SLC13A3 encodes the plasma membrane Na+ /dicarboxylate cotransporter 3, which imports inside the cell 4 to 6 carbon dicarboxylates as well as N-acetylaspartate (NAA). SLC13A3 is mainly expressed in kidney, in astrocytes, and in the choroid plexus. We describe two unrelated patients presenting with acute, reversible (and recurrent in one) neurological deterioration during a febrile illness. Both patients exhibited a reversible leukoencephalopathy and a urinary excretion of α-ketoglutarate (αKG) that was markedly increased and persisted over time. In one patient, increased concentrations of cerebrospinal fluid NAA and dicarboxylates (including αKG) were observed. Extensive workup was unsuccessful, and a genetic cause was suspected. METHODS: Whole exome sequencing (WES) was performed. Our teams were connected through GeneMatcher. RESULTS: WES analysis revealed variants in SLC13A3. A homozygous missense mutation (p.Ala254Asp) was found in the first patient. The second patient was heterozygous for another missense mutation (p.Gly548Ser) and an intronic mutation affecting splicing as demonstrated by reverse transcriptase polymerase chain reaction performed in muscle tissue (c.1016 + 3A > G). Mutations and segregation were confirmed by Sanger sequencing. Functional studies performed on HEK293T cells transiently transfected with wild-type and mutant SLC13A3 indicated that the missense mutations caused a marked reduction in the capacity to transport αKG, succinate, and NAA. INTERPRETATION: SLC13A3 deficiency causes acute and reversible leukoencephalopathy with marked accumulation of αKG. Urine organic acids (especially αKG and NAA) and SLC13A3 mutations should be screened in patients presenting with unexplained reversible leukoencephalopathy, for which SLC13A3 deficiency is a novel differential diagnosis. ANN NEUROL 2019;85:385-395.
OBJECTIVE:SLC13A3 encodes the plasma membrane Na+ /dicarboxylate cotransporter 3, which imports inside the cell 4 to 6 carbon dicarboxylates as well as N-acetylaspartate (NAA). SLC13A3 is mainly expressed in kidney, in astrocytes, and in the choroid plexus. We describe two unrelated patients presenting with acute, reversible (and recurrent in one) neurological deterioration during a febrile illness. Both patients exhibited a reversible leukoencephalopathy and a urinary excretion of α-ketoglutarate (αKG) that was markedly increased and persisted over time. In one patient, increased concentrations of cerebrospinal fluid NAA and dicarboxylates (including αKG) were observed. Extensive workup was unsuccessful, and a genetic cause was suspected. METHODS: Whole exome sequencing (WES) was performed. Our teams were connected through GeneMatcher. RESULTS: WES analysis revealed variants in SLC13A3. A homozygous missense mutation (p.Ala254Asp) was found in the first patient. The second patient was heterozygous for another missense mutation (p.Gly548Ser) and an intronic mutation affecting splicing as demonstrated by reverse transcriptase polymerase chain reaction performed in muscle tissue (c.1016 + 3A > G). Mutations and segregation were confirmed by Sanger sequencing. Functional studies performed on HEK293T cells transiently transfected with wild-type and mutant SLC13A3 indicated that the missense mutations caused a marked reduction in the capacity to transport αKG, succinate, and NAA. INTERPRETATION:SLC13A3 deficiency causes acute and reversible leukoencephalopathy with marked accumulation of αKG. Urine organic acids (especially αKG and NAA) and SLC13A3 mutations should be screened in patients presenting with unexplained reversible leukoencephalopathy, for which SLC13A3 deficiency is a novel differential diagnosis. ANN NEUROL 2019;85:385-395.
Authors: Eva Lausberg; Sebastian Gießelmann; Joseph P Dewulf; Elsa Wiame; Anja Holz; Ramona Salvarinova; Clara D van Karnebeek; Patricia Klemm; Kim Ohl; Michael Mull; Till Braunschweig; Joachim Weis; Clemens J Sommer; Stephanie Demuth; Claudia Haase; Claudia Stollbrink-Peschgens; François-Guillaume Debray; Cecile Libioulle; Daniela Choukair; Prasad T Oommen; Arndt Borkhardt; Harald Surowy; Dagmar Wieczorek; Norbert Wagner; Robert Meyer; Thomas Eggermann; Matthias Begemann; Emile Van Schaftingen; Martin Häusler; Klaus Tenbrock; Lambert van den Heuvel; Miriam Elbracht; Ingo Kurth; Florian Kraft Journal: J Clin Invest Date: 2021-06-15 Impact factor: 14.808
Authors: Yan Wang; Vanessa Hull; Sarah Sternbach; Brad Popovich; Travis Burns; Jennifer McDonough; Fuzheng Guo; David Pleasure Journal: Ann Neurol Date: 2021-09-24 Impact factor: 11.274
Authors: David B Sauer; Jinmei Song; Bing Wang; Jacob K Hilton; Nathan K Karpowich; Joseph A Mindell; William J Rice; Da-Neng Wang Journal: Nature Date: 2021-02-17 Impact factor: 49.962
Authors: David B Sauer; Jennifer J Marden; Joseph C Sudar; Jinmei Song; Christopher Mulligan; Da-Neng Wang Journal: Nat Commun Date: 2022-05-12 Impact factor: 17.694
Authors: Sofia Milosavljevic; Kevin E Glinton; Xiqi Li; Cláudia Medeiros; Patrick Gillespie; John R Seavitt; Brett H Graham; Sarah H Elsea Journal: Metabolites Date: 2022-04-14